[1]
A. Mikulska and A. Kocur, “Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring?”, Prosp. Pharm. Sc., vol. 21, no. 4, pp. 40–47, Nov. 2023.